BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38688707)

  • 1. Epidemiology of idiopathic pulmonary fibrosis: opportunities and hurdles for population-level studies of rare disease.
    Marinescu DC; Wong AW
    Thorax; 2024 Jun; 79(7):603-604. PubMed ID: 38688707
    [No Abstract]   [Full Text] [Related]  

  • 2. Spatial and temporal variability of idiopathic pulmonary fibrosis cases in Silesian Voivodeship in years 2006-2010.
    Niewiadomska E; Kowalska M; Zejda JE
    Int J Occup Med Environ Health; 2017 Jun; 30(4):593-601. PubMed ID: 28584328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
    Collard HR; Ryerson CJ; Corte TJ; Jenkins G; Kondoh Y; Lederer DJ; Lee JS; Maher TM; Wells AU; Antoniou KM; Behr J; Brown KK; Cottin V; Flaherty KR; Fukuoka J; Hansell DM; Johkoh T; Kaminski N; Kim DS; Kolb M; Lynch DA; Myers JL; Raghu G; Richeldi L; Taniguchi H; Martinez FJ
    Am J Respir Crit Care Med; 2016 Aug; 194(3):265-75. PubMed ID: 27299520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.
    Harari S; Caminati A; Madotto F; Conti S; Cesana G
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122864
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.
    Raghu G
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122859
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of Rare Lung Diseases: The Challenges and Opportunities to Improve Research and Knowledge.
    McCarthy C; Lara Gallego B; Trapnell BC; McCormack FX
    Adv Exp Med Biol; 2017; 1031():419-442. PubMed ID: 29214586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
    Raghu G; Chen SY; Yeh WS; Maroni B; Li Q; Lee YC; Collard HR
    Lancet Respir Med; 2014 Jul; 2(7):566-72. PubMed ID: 24875841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.
    Moodley Y; Goh N; Glaspole I; Macansh S; Walters EH; Chapman S; Hopkins P; Reynolds PN; Zappala C; Cooper W; Mahar A; Ellis S; McCormack S; Darbishire W; Wood-Baker R; Corte TJ;
    Respirology; 2014 Oct; 19(7):1088-91. PubMed ID: 25123691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review.
    de Boer K; Lee JS
    Respirology; 2016 Aug; 21(6):995-1004. PubMed ID: 26365251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
    Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology.
    Ley B; Collard HR
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1147-8. PubMed ID: 26568236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Idiopatic pulmonary fibrosis: A new paradigm].
    Avdeev SN
    Ter Arkh; 2017; 89(1):112-122. PubMed ID: 28635908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global incidence and prevalence of idiopathic pulmonary fibrosis.
    Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
    Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease and idiopathic pulmonary fibrosis.
    Pashinsky YY; Jaffin BW; Litle VR
    Mt Sinai J Med; 2009 Feb; 76(1):24-9. PubMed ID: 19170215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic pulmonary fibrosis: an Australian perspective.
    Prasad J; Holland AE; Glaspole I; Westall G
    Intern Med J; 2016 Jun; 46(6):663-8. PubMed ID: 27257148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis from a tertiary care centre in Pakistan.
    Sarwar Zubairi AB; Ahmad H; Hassan M; Siddiqui F; Iqbal N; Riaz M; Irfan M
    J Pak Med Assoc; 2021 Oct; 71(10):2330-2334. PubMed ID: 34974565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis: What nurses need to know.
    Pruitt B
    Nursing; 2021 Jan; 51(1):22-29. PubMed ID: 33346613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
    Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
    Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Of Idiopathic Pulmonary Fibrosis In Pakistani Population: A Matched Case-Control Studyy.
    Sarwar Zubairi AB; Rabbani U; Hassan M; Fatmi Z; Ahmed N; Ali AS; Rizvi N
    J Pak Med Assoc; 2023 Sep; 73(9):1782-1787. PubMed ID: 37817684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
    Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
    Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.